Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 48

Results For "CHI"

5487 News Found

Lupin receives US $50 mn on achieving cancer milestone
News | May 28, 2021

Lupin receives US $50 mn on achieving cancer milestone

MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination


Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma
News | May 25, 2021

Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma

The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr


Orchid Pharma Q4FY21 consolidated loss at Rs. 24.72 Cr
News | May 23, 2021

Orchid Pharma Q4FY21 consolidated loss at Rs. 24.72 Cr

The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021


Orchid Pharma develops new molecule OCID-5090
News | May 23, 2021

Orchid Pharma develops new molecule OCID-5090

Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.


Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI
News | April 05, 2021

Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI

TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India


Jan Aushadi Kendras to achieve record sales of Rs. 600 Cr in FY 2020-21
News | January 15, 2021

Jan Aushadi Kendras to achieve record sales of Rs. 600 Cr in FY 2020-21

In FY 2020-2021 (upto 12th January 2021) Jan Aushadhi Kendras have completed sales of Rs. 484 crores at 7,064 Pradhan Mantri Bhartiya Jan Aushadhi Kendras


Merck names Miguel Alcalde to lead global commercial strategy;  Monia Vial to head North America
People | June 26, 2026

Merck names Miguel Alcalde to lead global commercial strategy; Monia Vial to head North America

The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire


Merck wins EU nod for KEYTRUDA-Padcev regimen in muscle-invasive bladder cancer
Drug Approval | June 26, 2026

Merck wins EU nod for KEYTRUDA-Padcev regimen in muscle-invasive bladder cancer

The approval is based on results from the pivotal Phase 3 KEYNOTE-905 trial


Reliance-backed Karkinos Healthcare crosses 1 lakh cervical cancer screening in India
News | June 26, 2026

Reliance-backed Karkinos Healthcare crosses 1 lakh cervical cancer screening in India

Karkinos’ model aims to close both gaps by combining World Health Organization-recommended HPV DNA testing with a digitally enabled continuum of care


Dr. GSK Velu recognised for lifetime contribution to healthcare innovation
Healthcare | June 26, 2026

Dr. GSK Velu recognised for lifetime contribution to healthcare innovation

The Trivitron Healthcare CMD and FICCI Tamil Nadu Chairman was honoured for advancing indigenous innovation and strengthening India's healthcare ecosystem